Clinical Trial Update: A Study of ATB1651 in Adults With Mild to Moderate Onchomycosis [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating ATB1651 for mild to moderate onychomycosis is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Onychomycosis

Drugs mentioned

• ATB1651

Snippet

Sponsor: AmtixBio Co., Ltd. | Conditions: Onychomycosis | Phase 2 | Status: RECRUITING